Mackenzie Financial Corp raised its holdings in Humana Inc (NYSE:HUM) by 3.6% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 6,642 shares of the insurance provider’s stock after buying an additional 232 shares during the quarter. Mackenzie Financial Corp’s holdings in Humana were worth $1,618,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of HUM. Sei Investments Co. lifted its stake in Humana by 22.7% in the second quarter. Sei Investments Co. now owns 26,416 shares of the insurance provider’s stock valued at $6,354,000 after buying an additional 4,884 shares during the period. Global X Management Co. LLC lifted its stake in Humana by 8.8% in the second quarter. Global X Management Co. LLC now owns 7,708 shares of the insurance provider’s stock valued at $1,855,000 after buying an additional 625 shares during the period. DekaBank Deutsche Girozentrale lifted its stake in Humana by 75.9% in the second quarter. DekaBank Deutsche Girozentrale now owns 53,169 shares of the insurance provider’s stock valued at $12,874,000 after buying an additional 22,934 shares during the period. Pitcairn Co. lifted its stake in Humana by 15.8% in the second quarter. Pitcairn Co. now owns 2,698 shares of the insurance provider’s stock valued at $650,000 after buying an additional 368 shares during the period. Finally, Convergence Investment Partners LLC acquired a new position in Humana in the second quarter valued at approximately $2,196,000. 94.19% of the stock is currently owned by hedge funds and other institutional investors.
Several brokerages have issued reports on HUM. BMO Capital Markets boosted their price target on Humana from $290.00 to $300.00 and gave the company an “outperform” rating in a research note on Friday, November 10th. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $242.00 target price (down from $245.00) on shares of Humana in a research report on Thursday, November 9th. BidaskClub lowered Humana from a “hold” rating to a “sell” rating in a research report on Thursday, August 17th. ValuEngine lowered Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, October 10th. Finally, Jefferies Group reaffirmed a “hold” rating and set a $257.00 target price on shares of Humana in a research report on Friday, October 13th. Twelve equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $255.80.
Shares of Humana Inc (NYSE HUM) traded up $2.59 during trading on Monday, reaching $256.49. The company had a trading volume of 985,100 shares, compared to its average volume of 1,380,953. Humana Inc has a 1-year low of $186.25 and a 1-year high of $264.56. The company has a market capitalization of $36,642.18, a P/E ratio of 21.89, a P/E/G ratio of 1.76 and a beta of 0.88. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.61 and a quick ratio of 1.61.
Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.27 by $0.12. Humana had a return on equity of 15.99% and a net margin of 3.49%. The business had revenue of $13.28 billion during the quarter, compared to the consensus estimate of $13.41 billion. During the same quarter in the prior year, the company posted $3.18 earnings per share. Humana’s revenue was down 3.0% compared to the same quarter last year. sell-side analysts anticipate that Humana Inc will post 11.63 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be issued a dividend of $0.40 per share. The ex-dividend date is Thursday, December 28th. This represents a $1.60 annualized dividend and a yield of 0.62%. Humana’s dividend payout ratio (DPR) is currently 12.59%.
ILLEGAL ACTIVITY NOTICE: This story was first published by Transcript Daily and is owned by of Transcript Daily. If you are reading this story on another website, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this story can be read at https://transcriptdaily.com/2017/12/11/humana-inc-hum-holdings-boosted-by-mackenzie-financial-corp.html.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc and related companies with MarketBeat.com's FREE daily email newsletter.